Selected research
Industry Growth & Trends
Global Ticagrelor Industry Growth and Trends Forecast to 2032
Market perspective
The global Ticagrelor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Ticagrelor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Ticagrelor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ticagrelor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ticagrelor include Sun Pharmaceutical, Johnson & Johnson, Merck, Eli Lilly, Pfizer, Bayer, Astrazeneca and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Ticagrelor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Ticagrelor market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ticagrelor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ticagrelor.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Ticagrelor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Ticagrelor Market by Company
Sun Pharmaceutical
Johnson & Johnson
Merck
Eli Lilly
Pfizer
Bayer
Astrazeneca
Boehringer Ingelheim
Ticagrelor Segment by Type
90 mg Tablet
60 mg Tablet
Ticagrelor Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Ticagrelor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ticagrelor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ticagrelor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ticagrelor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ticagrelor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Ticagrelor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 90 mg Tablet
- 60 mg Tablet
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Sun Pharmaceutical
- Johnson & Johnson
- Merck
- Eli Lilly
- Pfizer
- Bayer
- Astrazeneca
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Ticagrelor Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Ticagrelor Sales Estimates and Forecasts (2021-2032)
- 1.3 Ticagrelor Market by Type
- 1.3.1 90 mg Tablet
- 1.3.2 60 mg Tablet
- 1.4 Global Ticagrelor Market Size by Type
- 1.4.1 Global Ticagrelor Market Size Overview by Type (2021-2032)
- 1.4.2 Global Ticagrelor Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Ticagrelor Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Ticagrelor Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Ticagrelor Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Ticagrelor Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Ticagrelor Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Ticagrelor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Ticagrelor Industry Trends
- 2.2 Ticagrelor Industry Drivers
- 2.3 Ticagrelor Industry Opportunities and Challenges
- 2.4 Ticagrelor Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Ticagrelor Revenue (2021-2026)
- 3.2 Global Top Players by Ticagrelor Sales (2021-2026)
- 3.3 Global Top Players by Ticagrelor Price (2021-2026)
- 3.4 Global Ticagrelor Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ticagrelor Major Company Production Sites & Headquarters
- 3.6 Global Ticagrelor Company, Product Type & Application
- 3.7 Global Ticagrelor Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ticagrelor Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ticagrelor Players Market Share by Revenue in 2025
- 3.8.3 2025 Ticagrelor Tier 1, Tier 2, and Tier 3
4 Ticagrelor Regional Status and Outlook
- 4.1 Global Ticagrelor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Ticagrelor Historic Market Size by Region
- 4.2.1 Global Ticagrelor Sales in Volume by Region (2021-2026)
- 4.2.2 Global Ticagrelor Sales in Value by Region (2021-2026)
- 4.2.3 Global Ticagrelor Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Ticagrelor Forecasted Market Size by Region
- 4.3.1 Global Ticagrelor Sales in Volume by Region (2027-2032)
- 4.3.2 Global Ticagrelor Sales in Value by Region (2027-2032)
- 4.3.3 Global Ticagrelor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ticagrelor by Application
- 5.1 Ticagrelor Market by Application
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Ticagrelor Market Size by Application
- 5.2.1 Global Ticagrelor Market Size Overview by Application (2021-2032)
- 5.2.2 Global Ticagrelor Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Ticagrelor Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Ticagrelor Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Ticagrelor Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Ticagrelor Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Ticagrelor Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Ticagrelor Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sun Pharmaceutical
- 6.1.1 Sun Pharmaceutical Company Information
- 6.1.2 Sun Pharmaceutical Business Overview
- 6.1.3 Sun Pharmaceutical Ticagrelor Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sun Pharmaceutical Ticagrelor Product Portfolio
- 6.1.5 Sun Pharmaceutical Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Ticagrelor Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Johnson & Johnson Ticagrelor Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Merck
- 6.3.1 Merck Company Information
- 6.3.2 Merck Business Overview
- 6.3.3 Merck Ticagrelor Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merck Ticagrelor Product Portfolio
- 6.3.5 Merck Recent Developments
- 6.4 Eli Lilly
- 6.4.1 Eli Lilly Company Information
- 6.4.2 Eli Lilly Business Overview
- 6.4.3 Eli Lilly Ticagrelor Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Eli Lilly Ticagrelor Product Portfolio
- 6.4.5 Eli Lilly Recent Developments
- 6.5 Pfizer
- 6.5.1 Pfizer Company Information
- 6.5.2 Pfizer Business Overview
- 6.5.3 Pfizer Ticagrelor Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Pfizer Ticagrelor Product Portfolio
- 6.5.5 Pfizer Recent Developments
- 6.6 Bayer
- 6.6.1 Bayer Company Information
- 6.6.2 Bayer Business Overview
- 6.6.3 Bayer Ticagrelor Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Bayer Ticagrelor Product Portfolio
- 6.6.5 Bayer Recent Developments
- 6.7 Astrazeneca
- 6.7.1 Astrazeneca Company Information
- 6.7.2 Astrazeneca Business Overview
- 6.7.3 Astrazeneca Ticagrelor Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Astrazeneca Ticagrelor Product Portfolio
- 6.7.5 Astrazeneca Recent Developments
- 6.8 Boehringer Ingelheim
- 6.8.1 Boehringer Ingelheim Company Information
- 6.8.2 Boehringer Ingelheim Business Overview
- 6.8.3 Boehringer Ingelheim Ticagrelor Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Boehringer Ingelheim Ticagrelor Product Portfolio
- 6.8.5 Boehringer Ingelheim Recent Developments
7 North America by Country
- 7.1 North America Ticagrelor Sales by Country
- 7.1.1 North America Ticagrelor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Ticagrelor Sales by Country (2021-2026)
- 7.1.3 North America Ticagrelor Sales Forecast by Country (2027-2032)
- 7.2 North America Ticagrelor Market Size by Country
- 7.2.1 North America Ticagrelor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Ticagrelor Market Size by Country (2021-2026)
- 7.2.3 North America Ticagrelor Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Ticagrelor Sales by Country
- 8.1.1 Europe Ticagrelor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Ticagrelor Sales by Country (2021-2026)
- 8.1.3 Europe Ticagrelor Sales Forecast by Country (2027-2032)
- 8.2 Europe Ticagrelor Market Size by Country
- 8.2.1 Europe Ticagrelor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Ticagrelor Market Size by Country (2021-2026)
- 8.2.3 Europe Ticagrelor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Ticagrelor Sales by Country
- 9.1.1 Asia-Pacific Ticagrelor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Ticagrelor Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Ticagrelor Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Ticagrelor Market Size by Country
- 9.2.1 Asia-Pacific Ticagrelor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Ticagrelor Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Ticagrelor Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Ticagrelor Sales by Country
- 10.1.1 South America Ticagrelor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Ticagrelor Sales by Country (2021-2026)
- 10.1.3 South America Ticagrelor Sales Forecast by Country (2027-2032)
- 10.2 South America Ticagrelor Market Size by Country
- 10.2.1 South America Ticagrelor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Ticagrelor Market Size by Country (2021-2026)
- 10.2.3 South America Ticagrelor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Ticagrelor Sales by Country
- 11.1.1 Middle East and Africa Ticagrelor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Ticagrelor Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Ticagrelor Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Ticagrelor Market Size by Country
- 11.2.1 Middle East and Africa Ticagrelor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Ticagrelor Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Ticagrelor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Ticagrelor Value Chain Analysis
- 12.1.1 Ticagrelor Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Ticagrelor Production Mode & Process
- 12.2 Ticagrelor Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Ticagrelor Distributors
- 12.2.3 Ticagrelor Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst